Cell & Gene Therapy for Autoimmune Disorders
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT06938334
A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 15, 2025
Completion: Jun 15, 2029
Loading map...